Drupal.behaviors.print = function(context) {window.print();window.close();}>

Alnylam Starts Phase I Trial of Subcutaneous ATTR Drug

March 21, 2013

Alnylam Starts Phase I Trial of Subcutaneous ATTR Drug

 

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories